According to the data from Biotechnology Industry Organization (the BIO), the CAGR of China’s prescription drug market is expected to be 26%. Based on the 48 billion US dollars market size last year, it will reach 315 billion dollars in 2020.
On the 3rd BIO Convention in China lately, Mr. Greenwood, president and CEO of the BIO, expressed, the biotechnology market in China is growing steadily. Both sales and profit are increasing rapidly at double-digit rates. And the BIO plays an important role in the rising of China’s biotechnology industry.
Date: Nov. 21, 2013